Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Campus Walkways Are The New Runways: The First
- This 15-Foot Python Is the First Known Snake to Receive Electrochemotherapy for Cancer. Now, She’s Officially Free of the Disease
- Lindsay Clancy trial: psychologist says he doubts claim she was hallucinating
- Largest review of its kind confirms benefits of tai chi and other Chinese exercises
- Shokz Put Its New Open Wireless Earbuds on a Diet
- West Nile risk ‘high’ as second human case turns up, health officials say
- 6 Easy Lifestyle Changes That May Help Prevent Alzheimer’s Disease
- Improving access to medicines for patients with reduced hand function
Browsing: Patients
Dr. Gurinder S. Sidhu, senior medical director and U.S. Antiviral Medical Lead, Pfizer, discusses how Covid-19 remains a serious threat to the roughly 75% of American adults who qualify as high-risk, and pushes back against clinician complacency
Marie Noon at her home in Brighton, Michigan, with her dog, Ziggy. Despite being eligible for Medicaid, Marie was denied coverage in 2025 because of an error with the state’s benefits system. It took months of pushback before the state reversed its mistake. Even as a “tech-savvy” former bank manager, Marie says, she wanted to…
AT A GLANCE: Crohn’s disease is a condition that can affect any part of the digestive system. While it affects people throughout their lives in different ways, more treatment options are now available. Physicians are also finding promising lifestyle adjustments to help with the disease. Here are five things you will learn about Crohn’s disease from Sowmya…
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds especially well to tirzepatide, a medication that mimics two naturally occurring hormones involved in appetite and blood sugar regulation, moving the…
As predictive health tools become more accurate and personalized, much less is known about what people expect from these systems or what they need to confidently use them
Setmelanotide, a melanocortin-4 receptor agonist, significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The New England Journal of Medicine. Although focused primarily on patients with craniopharyngioma, this study addresses a clinically important survivorship issue: the management of…
More than 25% of Gen Z patients don’t have doctors. Experts weigh in on the cost of skipping care When most people think of going to the doctor, they think of going when they’re feeling sick or unwell. But here at Beaufort Memorial, physicians tell me that that might not be enough and that preventing…
Setmelanotide significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The New England Journal of Medicine.
RANGPUR, July 14, 2026 (BSS) – The Department of Social Services (DSS) distributed Taka 50 lakh among 100 helpless patients suffering from chronic diseases as a medical assistance grant to help them bear costly medical expenses.
Music, dance and meditation couldn’t change the outcome of Benjamin Goldberg’s battle with neuroblastoma, a rare nerve tissue cancer that took his life at age 8

